Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $121.8900 (-0.47%) ($121.6100 - $123.8800) on Wed. Sep. 7, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.91% (three month average) | RSI | 39 | Latest Price | $121.8900(-0.47%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(45%) XBI(44%) XLV(43%) VYM(38%) IWO(37%) | Factors Impacting UTHR price | UTHR will decline at least -0.955% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-6%) IPO(-5%) BNDX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.955% (StdDev 1.91%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
1 - 5 Day Possible Target | $118.9(-2.45%) | Resistance Level | $124.33 | 5 Day Moving Average | $122.55(-0.54%) | 10 Day Moving Average | $122.63(-0.6%) | 20 Day Moving Average | $124.33(-1.96%) | To recent high | -6% | To recent low | 24% | Market Cap | $5.407b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |